Email updates

Keep up to date with the latest news and content from BMC Musculoskeletal Disorders and BioMed Central.

Open Access Highly Accessed Study protocol

The effect of continuous ultrasound on chronic low back pain: protocol of a randomized controlled trial

Safoora Ebadi1*, Noureddin Nakhostin Ansari1, Nicholas Henschke2, Soofia Naghdi1 and Maurits W van Tulder3

Author Affiliations

1 Rehabilitation Faculty, Tehran University of Medical Sciences, Iran

2 The George Institute for Global Health, Sydney, Australia and EMGO Institute for Health & Care Research, Amsterdam, the Netherlands

3 Professor of Health Technology Assessment, Department of Health Sciences and EMGO Institute for Health & Care Research, Faculty of Earth & Life Sciences, VU University Amsterdam, the Netherlands

For all author emails, please log on.

BMC Musculoskeletal Disorders 2011, 12:59  doi:10.1186/1471-2474-12-59

Published: 16 March 2011

Abstract

Background

Chronic non-specific low-back pain (LBP) is one of the most common and expensive musculoskeletal disorders in industrialized countries. Similar to other countries in the world, LBP is a common health and socioeconomic problem in Iran. One of the most widely used modalities in the field of physiotherapy for treating LBP is therapeutic ultrasound. Despite its common use, there is still inconclusive evidence to support its effectiveness in this group of patients. This randomised trial will evaluate the effectiveness of continuous ultrasound in addition to exercise therapy in patients with chronic LBP.

Methods and design

A total of 46 patients, between the ages 18 and 65 years old who have had LBP for more than three months will be recruited from university hospitals. Participants will be randomized to receive continuous ultrasound plus exercise therapy or placebo ultrasound plus exercise therapy. These groups will be treated for 10 sessions during a period of 4 weeks. Primary outcome measures will be functional disability and pain intensity. Lumbar flexion and extension range of motion, as well as changes in electromyography muscle fatigue indices, will be measured as secondary outcomes. All outcome measures will be measured at baseline, after completion of the treatment sessions, and after one month.

Discussion

The results of this trial will help to provide some evidence regarding the use of continuous ultrasound in chronic LBP patients. This should lead to a more evidence-based approach to clinical decision making regarding the use of ultrasound for LBP.

Trial registration

Netherlands Trial Register (NTR): NTR2251